Recently, the diagnosis of insulinoma mainly depends on clinical symptoms and the assessment of serum glucose, insulin, C-peptide, and β-hydroxybutyrate levels (Dauben et al., 2019; Giannis et al., 2020). This evidence concerns the gene INS and pancreatic insulinoma.